Work

A phase I study of afatinib combined with carboplatin or carboplatin plus paclitaxel in patients (pts) with advanced solid tumors.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.2571

Authors: Fangfei Gao, Mary O'Brien, Debashis Sarker, Jaishree Bhosle, Timothy Anthony Yap, Martina Maria Uttenreuther-Fischer, Karine Pemberton, Rainer-Georg Goeldner, Sabrina Wiebe, Johann S. De Bono, James F. Spicer

Institutions: Guy's Hospital, King's College London, Royal Marsden NHS Foundation Trust, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United Kingdom), Institute of Cancer Research

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2786100229

Cites:

Cited by:

Related to: 10